Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3454)
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
2,087
Price
$57.76
Total Value
$120.55K
Shares Held After
104,395
% of Holdings
2.0%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
7,913
Price
$57.16
Total Value
$452.28K
Shares Held After
106,482
% of Holdings
6.9%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$54.03
Total Value
$109.90K
Shares Held After
227,490
% of Holdings
0.9%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
146,889
Price
$22.45
Total Value
$3.30M
Shares Held After
1,019,658
% of Holdings
12.6%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
239,351
Price
$21.74
Total Value
$5.20M
Shares Held After
1,166,547
% of Holdings
17.0%
Shattuck Labs, Inc. (STTK)
Shukla Abhinav A. — Chief Technical Officer
Shares
410
Price
$7.01
Total Value
$2.87K
Shares Held After
86,380
% of Holdings
0.5%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
14,745
Price
$14.03
Total Value
$206.87K
Shares Held After
154,811
% of Holdings
8.7%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
85,955
Price
$14.03
Total Value
$1.21M
Shares Held After
707,373
% of Holdings
10.8%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
25,000
Price
$37.39
Total Value
$934.63K
Shares Held After
60,000
% of Holdings
29.4%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
65,000
Price
$37.39
Total Value
$2.43M
Shares Held After
2,710,000
% of Holdings
2.3%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
16,072
Price
$23.44
Total Value
$376.73K
Shares Held After
15,805
% of Holdings
50.4%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
16,214
Price
$22.76
Total Value
$369.03K
Shares Held After
31,877
% of Holdings
33.7%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
22,714
Price
$21.95
Total Value
$498.57K
Shares Held After
48,091
% of Holdings
32.1%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
94
Price
$27.36
Total Value
$2.57K
Shares Held After
14,364
% of Holdings
0.7%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
692
Price
$26.00
Total Value
$17.99K
Shares Held After
14,458
% of Holdings
4.6%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
85
Price
$27.27
Total Value
$2.32K
Shares Held After
23,884
% of Holdings
0.4%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
712
Price
$26.00
Total Value
$18.51K
Shares Held After
23,969
% of Holdings
2.9%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
24
Price
$27.33
Total Value
$655.81
Shares Held After
81,042
% of Holdings
0.0%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
534
Price
$26.03
Total Value
$13.90K
Shares Held After
81,066
% of Holdings
0.7%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
7,600
Price
$45.89
Total Value
$348.76K
Shares Held After
519,227
% of Holdings
1.4%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
4,282
Price
$45.43
Total Value
$194.53K
Shares Held After
526,827
% of Holdings
0.8%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
9,200
Price
$44.43
Total Value
$408.76K
Shares Held After
531,109
% of Holdings
1.7%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
1,506
Price
$4.27
Total Value
$6.43K
Shares Held After
94,630
% of Holdings
1.6%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
5,905
Price
$4.27
Total Value
$25.21K
Shares Held After
605,408
% of Holdings
1.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
819
Price
$4.27
Total Value
$3.50K
Shares Held After
64,545
% of Holdings
1.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
1,859
Price
$4.27
Total Value
$7.94K
Shares Held After
157,703
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
1,036
Price
$4.27
Total Value
$4.42K
Shares Held After
91,428
% of Holdings
1.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
1,500
Price
$524.99
Total Value
$787.49K
Shares Held After
45,321
% of Holdings
3.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
200
Price
$650.15
Total Value
$130.03K
Shares Held After
17,303
% of Holdings
1.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
1,541
Price
$519.00
Total Value
$799.78K
Shares Held After
11,001
% of Holdings
12.3%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
3,000
Price
$40.00
Total Value
$120.00K
Shares Held After
19,225
% of Holdings
13.5%
ImmunityBio, Inc. (IBRX)
Cohen Cheryl — Director
Shares
131,210
Price
$9.50
Total Value
$1.25M
Shares Held After
125,386
% of Holdings
51.1%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
10,000
Price
$1.98
Total Value
$19.80K
Shares Held After
366,904
% of Holdings
2.7%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
44,838
Price
$22.59
Total Value
$1.01M
Shares Held After
230,713
% of Holdings
16.3%
Immunovant, Inc. (IMVT)
Venker Eric — Director
Shares
3,092
Price
$38.48
Total Value
$118.98K
Shares Held After
254,280
% of Holdings
1.2%
Intellia Therapeutics, Inc. (NTLA)
Dulac Edward J III — EVP, Chief Financial Officer
Shares
4,677
Price
$18.00
Total Value
$84.19K
Shares Held After
156,286
% of Holdings
2.9%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
2,161
Price
$13.64
Total Value
$29.48K
Shares Held After
213,009
% of Holdings
1.0%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
17,873
Price
$13.00
Total Value
$232.40K
Shares Held After
90,180
% of Holdings
16.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
24,335
Price
$23.33
Total Value
$567.74K
Shares Held After
208,504
% of Holdings
10.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
75,665
Price
$22.35
Total Value
$1.69M
Shares Held After
232,839
% of Holdings
24.5%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
9,821
Price
$2.49
Total Value
$24.45K
Shares Held After
2,641,308
% of Holdings
0.4%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
147
Price
$1.55
Total Value
$227.85
Shares Held After
73,135
% of Holdings
0.2%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
1,460
Price
$1.55
Total Value
$2.26K
Shares Held After
724,395
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
225
Price
$556.36
Total Value
$125.18K
Shares Held After
45,172
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
990
Price
$555.83
Total Value
$550.27K
Shares Held After
45,397
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
299
Price
$554.45
Total Value
$165.78K
Shares Held After
46,387
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,201
Price
$553.52
Total Value
$1.22M
Shares Held After
46,686
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,818
Price
$552.61
Total Value
$1.00M
Shares Held After
48,887
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,467
Price
$551.30
Total Value
$808.75K
Shares Held After
50,705
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
384
Price
$550.02
Total Value
$211.21K
Shares Held After
52,172
% of Holdings
0.7%
Showing 751–800 of 3454 transactions (page 16 of 70)